Shanghai, China

Xinci Xie


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):

Title: Xinci Xie: Innovator in Influenza Vaccine Development

Introduction

Xinci Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in the development of vaccines. His innovative work focuses on creating effective solutions to combat influenza viruses.

Latest Patents

Xinci Xie holds a patent for an immunogen designed for a broad-spectrum influenza vaccine. The patent, titled "Immunogen for broad-spectrum influenza vaccine and application thereof," describes a novel influenza immunogen that exhibits a broad-spectrum anti-influenza virus effect. The immunogen's sequence includes specific amino acid sequences, which are crucial for its effectiveness. The patent also outlines the use of a recombinant vector vaccine that utilizes this immunogen, aiming to induce a high-level T cell immune response in the local respiratory tract. This approach is intended to provide broad-spectrum protection against various influenza virus infections.

Career Highlights

Xinci Xie is affiliated with the Shanghai Public Health Clinical Center, where he conducts his research and development work. His career is marked by a commitment to advancing public health through innovative vaccine solutions. His contributions have the potential to significantly impact the management and prevention of influenza outbreaks.

Collaborations

Xinci Xie collaborates with esteemed colleagues, including Jianqing Xu and Xiaoyan Zhang. These partnerships enhance the research efforts and broaden the scope of their work in vaccine development.

Conclusion

Xinci Xie's innovative work in the field of influenza vaccines exemplifies the importance of research and development in public health. His contributions are paving the way for more effective immunization strategies against influenza viruses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…